Glycemic Excursion Minimization (GEM) to Outshine Health Disparities (GEM)
Glycemic Excursion Minimization (GEM) to Outshine Health Disparities: RCT
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Catherine L Davis, PhD
- Phone Number: 706-721-4534
- Email: katie.davis@augusta.edu
Study Locations
-
-
Georgia
-
Augusta, Georgia, United States, 30912
- Recruiting
- Georgia prevention institute
-
Principal Investigator:
- Catherine L Davis, PhD
-
Contact:
- Andre Soares, PT MS
- Phone Number: 706-721-4534
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- type 2 diabetes
- capable of making dietary and physical activity changes
Exclusion Criteria:
- on insulin or secretagogue
- on medications that impede weight loss (e.g., prednisone)
- pregnant or planning pregnancy in the next 2 months
- no history of moderate to severe hypoglycemia
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: GEM Intervention
A lifestyle coach will deliver the GEM intervention over 4 weeks in person and/or virtually (synchronously) to permit interaction with participants.
A pocket-sized manual will be provided with 4 units corresponding to session topics, and diary pages to record glucose responses to food and physical activity (PA).
Session 1: Introduce GEM, identify personal motivation, learn about foods that cause glucose to go high (high glycemic load (GL) foods) and those that do not (low GL foods), learn how physical activity affects glucose, and begin monitoring how these choices affect glucose.
Session 2: Replacement, substitution, and portion control to reduce consumption of high GL foods.
Session 3: Increasing PA and reducing sedentary behavior, esp.
after a meal.
Session 4: Ways to continue lifestyle changes over a lifetime, handle relapses, and thank loved ones for their support.
Text message reminders may be sent to participants between sessions to prompt diary entries and for encouragement.
|
Lifestyle coaching
|
|
No Intervention: Waitlist
Participants will be invited to receive the GEM intervention after they posttest, the next time it is offered.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline on percent time in range from continuous glucose monitor at post-intervention
Time Frame: Baseline week and post-intervention week. From baseline week to the week after end of intervention or waitlist period, up to 6 weeks
|
Difference in percent of time in range (70-180 mg/dL) from continuous glucose monitor data.
Change = post intervention week minus baseline week.
|
Baseline week and post-intervention week. From baseline week to the week after end of intervention or waitlist period, up to 6 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Catherine L Davis, PhD, Augusta University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 1974851
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.